Related Experiment Video
Updated: Aug 7, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
C-20 cyclopropyl vitamin D3 analogs
Milan R Uskokovic1, Percy Manchand, Stanislaw Marczak
1BioXell, Inc., Nutley, NJ 07110, USA.
Novel vitamin D analogs, including C-20 cyclopropylcalcitriol, show enhanced activity and reduced hypercalcemia compared to calcitriol. These vitamin D derivatives resist metabolic degradation, boosting their biological efficacy.
Area of Science:
- Medicinal Chemistry
- Endocrinology
- Immunology
Background:
- 1,25-dihydroxy vitamin D3 (calcitriol) is a crucial hormone with therapeutic potential.
- Modifications to the calcitriol structure can enhance its biological activity and therapeutic index.
- Understanding structure-activity relationships is key to developing improved vitamin D analogs.
Purpose of the Study:
- To synthesize and evaluate novel vitamin D analogs with enhanced biological activity.
- To investigate the impact of structural modifications on calcitriol's potency and metabolic stability.
- To assess the in vivo effects, including hypercalcemia induction and immune modulation, of these new analogs.
Main Methods:
- Synthesis of spiro[cyclopropane-1, 20'-calcitriol] (C-20 cyclopropylcalcitriol) and other modified vitamin D analogs.
- Assessment of biological activity in Mixed Lymphocyte Reaction (MLR) for interferon-gamma release suppression.
- Evaluation of hypercalcemia in mouse models at various dosage levels.
- Metabolic stability studies in UMR 106 cells, focusing on side-chain oxidation.
- Structure-activity relationship analysis of the novel vitamin D analogs.
Main Results:
- C-20 cyclopropylcalcitriol demonstrated significantly higher activity in MLR for suppressing interferon-gamma release compared to calcitriol.
- Hypercalcemia was induced in mice at a ten-fold lower dose for C-20 cyclopropylcalcitriol relative to calcitriol.
- Introduction of the Delta16,17-double bond and side-chain modifications (e.g., trifluoromethyl groups) yielded highly active vitamin D analogs.
- The C-16 double bond in cyclopropyl analogs prevented metabolic side-chain oxidation at the C-24 oxo level in UMR 106 cells.
- Enhanced biological activity is partly attributed to improved resistance to metabolic degradation.
Conclusions:
- Novel vitamin D analogs, particularly C-20 cyclopropylcalcitriol, exhibit superior potency and immune-modulatory effects compared to calcitriol.
- Structural modifications, including cyclopropanation and side-chain alterations, enhance vitamin D analog efficacy and metabolic stability.
- These findings support the development of more effective vitamin D-based therapeutics with improved pharmacological profiles.
Related Concept Videos
Pharmaceutical Equivalents
Cycloalkanes
The IUPAC nomenclature of cycloalkanes follows similar rules that apply to...
Cycloaddition Reactions: Overview
Antiviral Nucleoside Inhibitors
Disubstituted Cyclohexanes: cis-trans Isomerism
In cyclohexane, the substituents can occupy different positions generating distinct isomers.
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
